Rifadin IV Alternatives Compared
| Rifadin IV (rifampin) | Vancomycin | Ceftriaxone |
|
|---|
| Rifadin IV (rifampin) | Vancomycin | Ceftriaxone |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bartonellosis, Endocarditis, Haemophilus influenzae Prophylaxis, Legionella Pneumonia, Leprosy, Leprosy - Borderline, Leprosy - Tuberculoid, Meningitis, Meningococcal Disease... View more |
Prescription only
Vancomycin is an antibiotic that may be used in the treatment of C. difficile-associated diarrhea or enterocolitis when given orally, or other severe infections when given intravenously (IV)... View more |
Prescription only
Prescribed for Bacterial Infection, Bone infection, Bacterial Endocarditis Prevention, Bacteremia, Bronchitis, Chancroid, Conjunctivitis, Endocarditis, Endometritis, Epididymitis - Non-Specific... View more |
Related suggestions Endocarditis
|
|||||||||||||||||||||||
| More about Rifadin IV (rifampin) | More about Vancomycin | More about Ceftriaxone | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Vancomycin has an average rating of 6.5 out of 10 from a total of 57 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 26% reported a negative effect. |
Ceftriaxone has an average rating of 8.5 out of 10 from a total of 176 ratings on Drugs.com. 82% of reviewers reported a positive effect, while 9% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
|
View all Rifadin IV side effects |
View all Vancomycin side effects |
View all Ceftriaxone side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
| Lower cost generic approved |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Rifadin IV prices |
View all Vancomycin prices |
View all Ceftriaxone prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other rifampin brands include: Rifadin, Rimactane | Firvanq, Vancocin, Vancocin HCl, Vancocin HCl Pulvules |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
4 hours |
5.2 hours |
8 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 757 drugs are known to interact with Rifadin IV:
|
A total of 176 drugs are known to interact with Vancomycin:
|
A total of 58 drugs are known to interact with Ceftriaxone:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
July 13, 1983 |
December 21, 1984 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.